Anvest Score
38/100
Valuation
92/100
Quality
0/100
Growth
—
OmittedHealth
30/100
Momentum
31/100
- Valuation92
- Quality0
- Growth—
- Health30
- Momentum31
Loading company profile…
Fundamentals
P/E Ratio (TTM)
—
Sector median P/E
21.72
P/B Ratio
—
Sector median P/B
2.6
EPS (TTM)
₹-1.01
Market Cap
₹30.25 Cr
ROE
-1.05%
ROCE
-1.05%
Profit Margin
175.76%
JOHNSON PHARMACARE LIMITED FAQs
3 topicsExpandCollapse
JOHNSON PHARMACARE LIMITED FAQs
3 topicsWhat does the JOHNSON PHARMACARE LIMITED (JOHNPHARMA) stock page cover?
JOHNSON PHARMACARE LIMITED on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.
What are the current headline metrics for JOHNPHARMA?
JOHNSON PHARMACARE LIMITED is currently shown with a delayed price near ₹0.45, P/E N/A, and ROE -1.05%.
Does the JOHNPHARMA page provide investment advice?
No. The JOHNPHARMA page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.
Keep exploring